Heron Therapeutics
HRTX
#7354
Rank
C$0.51 B
Marketcap
$3.35
Share price
-3.29%
Change (1 day)
-16.37%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.67. In 2022 the company made an earnings per share (EPS) of -$2.47 an increase over its 2021 EPS that were of -$3.21.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-36%
2022-$2.47-23.11%
2021-$3.21-10%
2020-$3.57-0%
2019-$3.571.21%
2018-$3.52-32.7%
2017-$5.23-19.34%
2016-$6.4954.76%
2015-$4.191.73%
2014-$4.12-16.23%
2013-$4.9291.67%
2012-$2.57-31.45%
2011-$3.75-27.06%
2010-$5.13-43.75%
2009-$9.13-57.33%
2008-$21.39-82.92%
2007-$125.2220.61%
2006-$103.83175.76%
2005-$37.65-21.43%
2004-$47.92100%
2003-$23.96-38.24%
2002-$38.79161.54%
2001-$14.83-106.46%
2000$229.462051.55%
1999$10.67839.73%
1998$1.13-105.48%
1997-$20.73-88.16%
1996-$175.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.85-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.32 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.24-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.35 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA